Patents by Inventor David Broadhurst

David Broadhurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of risk of pre-eclampsia
    Patent number: 10564146
    Abstract: A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: February 18, 2020
    Assignee: University College Cork, National University of Ireland, Cork
    Inventors: Louise Kenny, Philip Newton Baker, David Broadhurst
  • Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
    Patent number: 10408844
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a subject. The methods and compositions involve measurement of at least one of proteins: IL-16, IL-7, VEGF, CXCL9, CX3CL1, CCL24, CCL19, and CCL11 in a body fluid sample of a subject suspected of having CFS/ME. Levels of one or more of the aforementioned proteins can be used to facilitate a diagnosis of a CFS/ME and/or confirm a diagnosis of CFS/ME. The methods and compositions of the present disclosure also find use in screening subjects for clinical trials and facilitating treatment decisions for a subject.
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: September 10, 2019
    Assignee: The Governors of the University of Alberta
    Inventors: Abdolamir Landi, David Broadhurst, D. Lorne J. Tyrrell, Michael Houghton
  • DETECTION OF RISK OF PRE-ECLAMPSIA
    Publication number: 20190056380
    Abstract: A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.
    Type: Application
    Filed: May 16, 2018
    Publication date: February 21, 2019
    Applicant: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK
    Inventors: Louise Kenny, Philip Newton Baker, David Broadhurst
  • Methods and Compositions in Diagnosis of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
    Publication number: 20180011110
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a subject. The methods and compositions involve measurement of at least one of proteins: IL-16, IL-7, VEGF, CXCL9, CX3CL1, CCL24, CCL19, and CCL11 in a body fluid sample of a subject suspected of having CFS/ME. Levels of one or more of the aforementioned proteins can be used to facilitate a diagnosis of a CFS/ME and/or confirm a diagnosis of CFS/ME. The methods and compositions of the present disclosure also find use in screening subjects for clinical trials and facilitating treatment decisions for a subject.
    Type: Application
    Filed: January 26, 2016
    Publication date: January 11, 2018
    Inventors: Abdolamir Landi, David Broadhurst, D. Lorne J. Tyrrell, Michael Houghton
  • DETECTION OF RISK OF PRE-ECLAMPSIA
    Publication number: 20160223517
    Abstract: A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.
    Type: Application
    Filed: January 7, 2016
    Publication date: August 4, 2016
    Applicant: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK
    Inventors: Louise Kenny, Philip Newton Baker, David Broadhurst
  • Detection of risk of pre-eclampsia
    Patent number: 9262582
    Abstract: A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: February 16, 2016
    Assignee: University College Cork, National University of Ireland, Cork
    Inventors: Louise Kenny, Philip Newton Baker, David Broadhurst
  • DETECTION OF RISK OF PRE-ECLAMPSIA
    Publication number: 20130073212
    Abstract: A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.
    Type: Application
    Filed: December 21, 2010
    Publication date: March 21, 2013
    Applicant: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK
    Inventors: Louise Kenny, Philip Newton Baker, David Broadhurst